To the Editor: We are grateful to Plagemann et al. for their constructive comments on wider aspects of the field we discussed in our article. The title and main substance of our article was a factual summary of the results of our experiments on rats, involving feeding rat dams a low-protein diet during pregnancy and lactation. This manipulation results in fetal and early postnatal growth restriction. It was not our intention to review all of the literature in this field, but rather, in an invited lecture, to review the progress of our own research. We apologise if we caused unrest by the focus of our article. We did not state that low birthweight is a cause of adult obesity, although there are data to suggest that this is true in some circumstances.
We entirely agree with Plagemann et al. that the roles played by changes in fetal growth, and indeed the time points during pregnancy at which these changes occur, need to be systematically investigated. These studies will need to distinguish between infants of high birthweight who are normally developed and those who are macrosomic [1] . The possible contribution of changes in early postnatal growth to adult disease also needs to be addressed. In our most recent experiments we have sought to distinguish between the effects of fetal growth restriction and early postnatal growth restriction, and this has produced some startling results [2] . It will also be important to determine which changes in postnatal growth are due to antenatal programming, for example programmed overexpression of the insulin receptor [3] , and which are induced by the postnatal environment, for example overfeeding.
It has been known for many years through manipulation of litter size that, in the rat, nutrition during the lactation period has long-term effects on appetite [4] . We have shown recently that programming of appetite during this period in the mouse is powerful enough to prevent early excess weight gain in response to a highly palatable diet [5] .
It is gratifying that the discovery of strong links between early human growth and adult risk of Type 2 diabetes [6] and the metabolic syndrome [7] have shown the great importance of this area of research in understanding these health problems.
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